Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,326 | 73 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $405.87 | 20 | $0 (2024) |
| Lilly USA, LLC | $141.26 | 10 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $128.45 | 8 | $0 (2024) |
| Amgen Inc. | $120.09 | 7 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $89.10 | 5 | $0 (2023) |
| Novo Nordisk Inc | $81.70 | 4 | $0 (2024) |
| PFIZER INC. | $78.26 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $44.23 | 3 | $0 (2024) |
| UCB, Inc. | $43.94 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $37.66 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,035 | 57 | ABBVIE INC. ($375.31) |
| 2023 | $199.35 | 11 | JAZZ PHARMACEUTICALS INC. ($89.10) |
| 2022 | $79.05 | 4 | Novartis Pharmaceuticals Corporation ($37.66) |
| 2021 | $12.31 | 1 | AbbVie Inc. ($12.31) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: PSYCHIATRY | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Gastroenterology | ||||||
| 12/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.29 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: PAIN | ||||||
| 11/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Gastroenterology | ||||||
| 11/03/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Gastroenterology | ||||||
| 09/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Inflammation | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Gastroenterology | ||||||
| 09/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Inflammation | ||||||
| 08/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $122.80 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 417 | 597 | $129,786 | $32,172 |
| 2022 | 6 | 305 | 477 | $92,760 | $23,323 |
| 2021 | 2 | 65 | 80 | $21,282 | $5,982 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 127 | 220 | $66,880 | $14,859 | 22.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 81 | 81 | $28,998 | $8,691 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 158 | $32,548 | $7,468 | 22.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 91 | 138 | $1,360 | $1,154 | 84.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 151 | $45,904 | $9,986 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 102 | 156 | $32,136 | $8,422 | 26.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 30 | 30 | $10,740 | $3,308 | 30.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 13 | 13 | $2,119 | $887.74 | 41.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 13 | $949.00 | $382.02 | 40.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 71 | 114 | $912.00 | $336.87 | 36.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 49 | $14,896 | $4,107 | 27.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 31 | $6,386 | $1,875 | 29.4% |
About Nicole Horn, PAC
Nicole Horn, PAC is a Medical healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518930700.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nicole Horn, PAC has received a total of $1,326 in payments from pharmaceutical and medical device companies, with $1,035 received in 2024. These payments were reported across 73 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,326).
As a Medicare-enrolled provider, Horn has provided services to 787 Medicare beneficiaries, totaling 1,154 services with total Medicare billing of $61,477. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Virginia Beach, VA
- Active Since 02/09/2006
- Last Updated 01/12/2010
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1518930700
Products in Payments
- VRAYLAR (Drug) $218.54
- UBRELVY (Drug) $143.42
- XIFAXAN (Drug) $128.45
- Otezla (Drug) $101.66
- EPIDIOLEX (Drug) $89.10
- Ozempic (Drug) $81.70
- NURTEC ODT (Drug) $78.26
- MOUNJARO (Drug) $75.17
- JARDIANCE (Drug) $66.09
- Fintepla (Drug) $43.94
- QULIPTA (Drug) $43.91
- KESIMPTA (Drug) $37.66
- AIRSUPRA (Drug) $28.67
- Cologuard Collection Kit (Device) $23.88
- AREXVY (Drug) $23.54
- VYVGART (Drug) $22.59
- FREESTYLE LIBRE 3 (Device) $19.19
- Repatha (Biological) $18.43
- Dexcom G6 Transmitter (Medical Supply) $17.97
- Dyanavel XR (Drug) $17.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Virginia Beach
Allison Boyd, Pa-C, PA-C
Medical — Payments: $111,983
Juliette Beristain, Pa-C, PA-C
Medical — Payments: $33,772
Lisa Deafenbaugh, P.a, P.A
Medical — Payments: $7,908
Yekaterina Jones
Medical — Payments: $7,794
Mrs. Martha Stoops
Medical — Payments: $5,239
Kristin Curry, Pa, PA
Medical — Payments: $4,501